OBD.Lライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (4 5月 2024 @ 00:35):

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally...

Stats
本日の出来高	528 737
平均出来高	538 509
時価総額	24.95M
EPS	£0 ( 2024-01-16 )
次の収益日	( £0 ) 2024-05-28
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.140
ATR14	£0.171 (2.06%)

Oxford Biodynamics PLC 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Oxford Biodynamics PLC 財務諸表

Annual	2023
収益:	£510 000
総利益:	£-6.83M (-1 338.43 %)
EPS:	£-0.0734

FY	2023
収益:	£510 000
総利益:	£-6.83M (-1 338.43 %)
EPS:	£-0.0734

FY	2022
収益:	£154 000
総利益:	£116 000 (75.32 %)
EPS:	£-0.0673

FY	2021
収益:	£341 000
総利益:	£-557 000 (-163.34 %)
EPS:	£-0.0722

Financial Reports:

No articles found.

Oxford Biodynamics PLC

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.